v3.26.1
RESTATEMENT
9 Months Ended
Sep. 30, 2025
Restatement  
RESTATEMENT

NOTE 5 – RESTATEMENT

 

Our interim financial statements for the three and nine months ended September 30, 2025, as previously filed with SEC on November 3, 2025, have been restated, to reverse the transaction of the other general and administrative expenses. The impact of this restatement on the Company’s Condensed Balance Sheet, Statements of Operations and Comprehensive Loss, and Statement of Cash Flows is reflected in the tables below:

 

 

CONDENSED BALANCE SHEETS

(Unaudited)

 

    Previously filed           Restated  
    September 30, 2025     Adjustment   September 30, 2025  
                   
CURRENT ASSETS                      
Prepayment   $ -     $ 8,250   $ 8,250  
TOTAL ASSETS   $ -     $ 8,250   $ 8,250  
                       
LIABILITIES AND STOCKHOLDERS’ EQUITY                      
CURRENT LIABILITIES                      
Accounts payable and accrued liabilities   $ 46,447     $ -   $ 46,447  
Amount due to the sole officer and director (non-interest bearing and due on demand)     46,028       -     46,028  
TOTAL CURRENT LIABILITIES     92,475       -     92,475  
TOTAL LIABILITIES     92,475       -     92,475  
                       
STOCKHOLDERS’ EQUITY (DEFICIT)                      
Common stock, $0.001 par value, 75,000,000 shares authorized, 3,870,600 shares issued and outstanding as of September 30, 2025 and December 31, 2024 respectively     3,871       -     3,871  
Additional paid-in capital     76,646       -     76.646  
Accumulated deficit     (172,992 )     8,250     (164,742 )
TOTAL STOCKHOLDERS’ DEFICIT     (92,475 )     8,250     (84,225 )
                       
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ -     $ 8,250   $ 8,250  

 

 

 

 

 

 F-7

 

 

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

For three months ended September 30, 2025

 

    Previously filed           Restated  
    Three months ended September 30, 2025     Adjustment   Three months ended September 30, 2025  
                   
REVENUE   -     $  -   $  -  
COST OF REVENUES     -       -     -  
GROSS PROFIT     -       -     -  
                       
OPERATING EXPENSES                      
Professional fees     11,800       -     11,800  
Other general and administrative expenses     13,547       (8,250 )   5,297  
TOTAL OPERATING EXPENSES     25,347       (8,250 )   17,097  
                       
OPERATING LOSS     (25,347     (8,250 )   (17,097
                       
OTHER INCOME (EXPENSES)     -       -     -  
                       
LOSS BEFORE INCOME TAX     (25,347     (8,250 )   (17,097
                       
INCOME TAX EXPENSE     -       -     -  
                       
NET LOSS   $ (25,347   $ (8,250 ) $ (17,097
                       
Other comprehensive income                      
    Foreign currency translation adjustment                      
COMPREHENSIVE LOSS   $ (25,347 )   $ (8,250 ) $ (17,097 )
                       
Net loss per share - Basic and diluted   $ (0.01 )   $ (0.00 ) $ (0.00 )
                       
Weighted Average Number of shares outstanding – Basis and diluted   $ 3,870,600     $ 3,870,600   $ 3,870,600  
                         

 

For nine months ended September 30, 2025

 

    Previously filed           Restated    
    Nine months ended September 30, 2025     Adjustment   Nine months ended September 30, 2025    
                     
REVENUE   -     $  -   $  -  
COST OF REVENUES     -       -     -  
GROSS PROFIT     -       -     -  
                       
OPERATING EXPENSES                      
Professional fees     11,800       -     11,800  
Other general and administrative expenses     16,563       (8,250 )   8,313  
TOTAL OPERATING EXPENSES     37,863       (8,250 )   29,613  
                       
OPERATING LOSS     (37,863     (8,250 )   (29,613
                       
OTHER INCOME (EXPENSES)     -       -     -  
                       
LOSS BEFORE INCOME TAX     (37,863     (8,250 )   (29,613
                       
INCOME TAX EXPENSE     -       -     -  
                       
NET LOSS   $ (37,863   $ (8,250 ) $ (29,613
                       
Other comprehensive income                      
    Foreign currency translation adjustment                      
COMPREHENSIVE LOSS   $ (37,863 )   $ (8,250 ) $ (29,613 )
                       
Net loss per share - Basic and diluted   $ (0.01 )   $ (0.00 ) $ (0.01 )
                       
Weighted Average Number of shares outstanding – Basis and diluted   $ 3,870,600     $ 3,870,600   $ 3,870,600  
                             

 

 

F-8

 

 

CONDENSED STATEMENTS OF CASH FLOWS

 

    Previously filed           Restated    
    Nine months ended September 30, 2025     Adjustment   Nine months ended September 30, 2025    
                     
CASH FLOWS FROM OPERATING ACTIVITIES                    
Net loss   (37,863   $ 8,250   $  (29,613
Changes in operating assets and liabilities:                      
    Prepayment     -       (8,250 )   (8,250 )
    Accounts payable and accrued liabilities     37,363       -     37,363  
Net cash used in operating activities     (500 )     -     (500 )
                       
CASH FLOWS FROM FINANCING ACTIVITIES                      
Advances from the current sole officer and director     500       -     500  
Net cash provided by financing activitie     500       -     500  
                       
Net change in cash and cash equivalents     -       -     -  
Cash and cash equivalents, beginning of period     -       -     -  
CASH AND CASH EQUIVALENTS, END OF PERIOD   $ -     $ -   $ -  
                       
SUPPLEMENTAL CASH FLOWS INFORMATION                      
Cash paid for income taxes   $ -     $ -   $ -  
Cash paid for interest   $ -     $ -   $ -